Macquarie Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.3M | Buy |
|
|||||
|
2025
Q1 | $111M | Buy |
|
|||||
|
2024
Q4 | $93.6M | Buy |
|
|||||
|
2024
Q3 | $77.8M | Buy |
|
|||||
|
2024
Q2 | $59.3M | Sell |
|
|||||
|
2024
Q1 | $82M | Sell |
|
|||||
|
2023
Q4 | $77.7M | Buy |
|
|||||
|
2023
Q3 | $84.8M | Buy |
|
|||||
|
2023
Q2 | $92.8M | Sell |
|
|||||
|
2023
Q1 | $104M | Buy |
|
|||||
|
2022
Q4 | $108M | Buy |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | $113M | Sell |
|
|||||
|
2022
Q1 | $108K | Sell |
|
|||||
|
2021
Q4 | $104M | Buy |
|
|||||
|
2021
Q3 | $98.1M | Buy |
|
|||||
|
2021
Q2 | $80.1M | Buy |
|
|||||
|
2021
Q1 | $69.2M | Buy |
|
|||||
|
2020
Q4 | $34.8M | Sell |
|
|||||
|
2020
Q3 | $49.8M | Buy |
|
|||||
|
2020
Q2 | $38.6M | Sell |
|
|||||
|
2020
Q1 | $37M | Sell |
|
|||||
|
2019
Q4 | $44.5M | Buy |
|
|||||
|
2019
Q3 | $9.63M | Sell |
|
|||||
|
2019
Q2 | $8.64M | Buy |
|
|||||
|
2019
Q1 | $8.43M | Buy |
|
|||||
|
2018
Q4 | $9.13M | Sell |
|
|||||
|
2018
Q3 | $11.6M | Sell |
|
|||||
|
2018
Q2 | $10.8M | Buy |
|
|||||
|
2018
Q1 | $12.3M | Sell |
|
|||||
|
2017
Q4 | $12.4M | Sell |
|
|||||
|
2017
Q3 | $15.3M | Sell |
|
|||||
|
2017
Q2 | $15.2M | Sell |
|
|||||
|
2017
Q1 | $17.9M | Sell |
|
|||||
|
2016
Q4 | $24M | Sell |
|
|||||
|
2016
Q3 | $42.5M | Sell |
|
|||||
|
2016
Q2 | $143M | Buy |
|
|||||
|
2016
Q1 | $54.2M | Buy |
|
|||||
|
2015
Q4 | $57.4M | Buy |
|
|||||
|
2015
Q3 | $45.6M | Buy |
|
|||||
|
2015
Q2 | $49.3M | Buy |
|
|||||
|
2015
Q1 | $31.3M | Buy |
|
|||||
|
2014
Q4 | $23M | Sell |
|
|||||
|
2014
Q3 | $20.1M | Buy |
|
|||||
|
2014
Q2 | $17.2M | Buy |
|
|||||
|
2014
Q1 | $16.1M | Sell |
|
|||||
|
2013
Q4 | $21.1M | Buy |
|
|||||
|
2013
Q3 | $17.5M | Buy |
|
|||||
|
2013
Q2 | $12.3M | Buy |
|